[6-K] Haleon plc American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc disclosed director/PDMR share transactions showing that two senior officers participated in the company's Share Reward Plan. Adrian Morris (General Counsel) and Tamara Rogers (Chief Marketing Officer) each acquired 36 Partnership Shares at £3.563199 per share and were awarded 36 Matching Shares at nil cost, for an aggregated 72 shares each. The transactions occurred on 11 August 2025 on the London Stock Exchange and were announced by the company, reflecting routine compensation-related share acquisitions under its Share Reward Plan.

Positive

• Transparent disclosure of PDMR transactions in line with UK MAR requirements
• Use of Share Reward Plan with explicit purchase and matching-share mechanics disclosed (36 purchased, 36 matched per PDMR)

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine, transparent PDMR disclosures; small, plan-based awards rather than open-market purchases.

The notification documents compliant disclosure under UK Market Abuse Regulation for two PDMRs. Each officer acquired Partnership Shares and received Matching Shares under the company's Share Reward Plan, with the purchased tranche at £3.563199 and matching shares awarded at nil cost. This is a standard executive compensation action and demonstrates adherence to disclosure rules; the share counts reported are small and tied to the formal incentive plan rather than an ad hoc transfer.

Equity Analyst

TL;DR: Transaction immaterial to equity base; confirms executives receive equity via the firm's reward plan.

The filings show purchase and matching awards for two named PDMRs, with aggregated volumes of 72 shares each. The disclosed price for the purchased portion is explicit. Given the low volumes disclosed, these transactions are unlikely to affect share supply or signal a change in executive confidence materially. They are informative for governance transparency but not material to valuation based on the data provided.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	12 August 2025 - “Director/PDMR Shareholding”

99.1

​Haleon plc: Director/PDMR Shareholding

​

12 August 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

On 12 August 2025, the Company received notification of the following transaction as detailed below.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adrian Morris
2	Reason for the notification
a)	Position/status	General Counsel - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.563199	36
			£Nil	36 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	72
	- Price
	e)	Date of the transaction	11 August 2025
	f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tamara Rogers
2	Reason for the notification
a)	Position/status	Chief Marketing Officer - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.563199	36
			£Nil	36 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	72
	- Price
	e)	Date of the transaction	11 August 2025
	f)	Place of the transaction	London Stock Exchange (XLON)

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: August 12, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What did Haleon (HLN) disclose about director shareholdings?

Haleon disclosed that two PDMRs each acquired Partnership Shares and were awarded Matching Shares under the company's Share Reward Plan.

How many shares did each PDMR receive in the Haleon notice?

Each named PDMR acquired 36 Partnership Shares and received 36 Matching Shares, totalling 72 shares each.

At what price were the Partnership Shares purchased?

The Partnership Shares were purchased at £3.563199 per share; the Matching Shares were awarded at nil cost.

When and where were the transactions executed?

The transactions took place on 11 August 2025 on the London Stock Exchange (XLON).

Who were the PDMRs named in the Haleon 6-K filing?

The filing named Adrian Morris (General Counsel) and Tamara Rogers (Chief Marketing Officer) as the PDMRs.